Educating Sex Workers Is Best Weapon in Africa's AIDS Fight: Experts

Important note: Information in this article was accurate in 2001. The state of the art may have changed since the publication date.

Educating Sex Workers Is Best Weapon in Africa's AIDS Fight: Experts

Agence France Presse (12.12.01) - Thursday, December 13, 2001

Providing HIV awareness counseling to prostitutes in Africa is a life-saving strategy that is more than 2,000 times as cost- effective as treating AIDS patients with antiretroviral drugs, according to research presented Wednesday at the African AIDS conference in Burkina Faso.

Advising sex workers on risky practices and giving them condoms costs just $1.32 per year per life saved, according to a team from the Institute for Human Development at the University of California at Berkeley. By comparison, administering the antiretroviral drug cocktail costs about $3,800 per year per life saved. Even if generic drugs are used, the cost remains high - $3,016 per life-year saved - due to the expenses of administering the drugs and monitoring patients.

In making the presentation, Berkeley researcher Emiko Masaki said the figures were emphatic proof that precious dollars should be focused far more on preventing AIDS than on treating it. "Treatment and preventing are competing for the same funds," she said. "But resource allocation decisions affect the number of lives saved. Prevention should take a higher priority over treatment." Nevirapine, which helps prevent mother-to-baby HIV transmission, costs just $11 per life-year saved. Encouraging people to undergo HIV tests and providing safe sex counseling cost between $22 and $30 per life-year saved. The research is based on a comparison of seven previous studies on HIV prevention and treatment in sub-Saharan Africa, as well as the team's own estimates of drug costs.
011213
AD012159

Copyright © 2001 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .